University of Oulu

CAFFEIN - Cancer Associated Fibroblasts (CAF) Function in Tumor Expansion and Invasion (316610)

Saved in:
Description:
"Aim of the CAFFEIN network is to provide 10 early stage researchers (ESRs) and 2 exprerienced researchers (ERs) with excellent training in an industry relevant area of cancer research, complementary skills required for pharmaceutical industry, and knowledge in setting up biomedical start-up companies. To this end, the network comprises two full industrial partners: the established pharmaceutical company Medimmune, a global leader in immunopharmaceuticals, and the small biotech company Gimmune, which used breakthrough results in nanotechnology to establish a new enterprise. The research focus of CAFFEIN, which stands for Cancer Associated Fibroblasts (CAF) Function in Tumor Expansion and Invasion, is to understand the mechanisms, how fibroblastoid cells support tumor progression and metastasis formation. CAF biology is therefore rather complex, but the research groups of the CAFFEIN network cover many different aspects of it, thus having a critical mass to provide relevant training in this area. Training in complementary skills important for work in the pharmaceutical industry is provided by the industrial partner MedImmune, where communication with management, industrial project planning, IPR, etc. will be taught. Entrepreneurial skills, business plans, funding by venture capitalists, and patentability of research findings are highlights of the training provided by the industrial partner Gimmune. All this training is transmitted to the ESRs/ERs by networkwide events, secondments and tight research collaboration. Taken together, the CAFFEIN research training network combines the acquisition of excellent scientific knowledge in an area highly attractive for pharmaceutical industry with special education in relevant complementary skills that increase employment chances of the trained researchers in industry and that encourage them to translate their scientific results into products, thus improving health and economic welfare of European citizens."
see all

Subjects:
Grant Number: 316610
Cordis Record Number: 105030
Project Start Date: 2012-10-01
Project End Date: 2016-09-30
Project Funder: EC/FP7/SP3/PEOPLE
EC Special Clause: false
Datapilot: false
Open Access Mandate: false
Coordinator: KOBENHAVNS UNIVERSITET
Coordinator contact: Mathiesen, Tine
Coordinator EU Contribution: 612571.6
EU Max Contribution: 3312522.75
Total Cost: 3312522.75
Participant: MEDIMMUNE LIMITED
UNIVERSITE DE LIEGE
UNIVERSITEIT GENT
WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER
CENTRO DE NEUROCIENCIAS E BIOLOGIACELULAR ASSOCIACAO
TURUN YLIOPISTO
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT AM MAIN
OULUN YLIOPISTO
KAROLINSKA INSTITUTET
UNIVERSITETET I BERGEN
More information: Detailed project information (CORDIS)
Detailed project information (Openaire)
Copyright information: © European Union, 1994-2017 CORDIS, http://cordis.europa.eu/
All materials created by the OpenAIRE consortium are licensed under a Creative Commons Attribution 4.0 International License
  http://cordis.europa.eu/
https://creativecommons.org/licenses/by/4.0/